赞比亚卢萨卡大学教学医院2008-2015年五岁以下急性胃肠炎患儿轮状病毒疫苗引入前后流行的轮状病毒株多样性
赞比亚卢萨卡大学教学医院对2008-2015年五岁以下急性胃肠炎住院患儿进行轮状病毒监测。疫苗引入前(2008-2011年)4066份粪便样本中轮状病毒阳性1561份(38%),引入后(2012-2015年)3092份中阳性977份(32%)。优势G/P基因型组合在疫苗引入前后持续变化,作者认为这提示疫苗引入后流行株的自然年代变异,并强调需持续监测。
要点
- 疫苗引入前轮状病毒阳性率38%(1561/4066),引入后为32%(977/3092)。
- 疫苗引入前优势组合随年份变化,如2008年G1P[8](49%)、2009年G12P[6](24%)和G9P[8](22%)。
- 疫苗引入后2012-2015年G2P[4]和G2P[6]持续流行,2015年G2P[4]占54%。
核心结论
- 轮状病毒流行株的持续变化提示疫苗引入后循环轮状病毒株存在自然年代变异。
- 作者认为这些发现强调需要持续监测,以继续观察疫苗使用如何影响较长时间内的株进化,并评估轮状病毒株的任何正常季节性波动。
研究设计与样本
- 在赞比亚卢萨卡大学教学医院通过主动监测纳入五岁以下儿童,使用标准化WHO病例调查表。
- 纳入标准为24小时内≥3次稀便且因急性胃肠炎作为主要疾病住院的儿童。
- 粪便样本采用酶联免疫吸附试验检测A组轮状病毒抗原。
- 随机选取轮状病毒阳性样本进行逆转录聚合酶链反应G和P基因分型,部分混合感染采用核苷酸测序确认。
- 疫苗引入前(2008-2011年)纳入4150例,采集粪便样本4066份(98%);疫苗引入后(2012-2015年)纳入3168例,采集样本3092份(98%)。
主要发现
- 疫苗引入前轮状病毒抗原阳性1561/4066(38%),疫苗引入后阳性977/3092(32%)。
- 疫苗引入前最常见G和P基因型组合:2008年G1P[8](49%);2009年G12P[6](24%)和G9P[8](22%);2010年混合轮状病毒感染(32%)和G9P[8](20%);2011年G1P[6](46%)、G9P[6](16%)和混合感染(20%)。
- 疫苗引入后优势株:2012年G1P[8](25%)、G2P[4](28%)和G2P[6](23%);2013年G2P[4](36%)和G2P[6](44%);2014年G1P[8](43%)、G2P[4](9%)和G2P[6](24%);2015年G2P[4](54%)和G2P[6](20%)继续流行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following the introduction of rotavirus vaccine into the routine immunization schedule, the burden of rotavirus disease has significantly reduced in Zambia. Although rotavirus vaccines appear to confer good cross-protection against both vaccine and non-vaccine strains, concerns about strain replacement following vaccine implementation remain. We describe the diversity of the circulating rotavirus strains before and after the Rotarix® vaccine was introduced in Lusaka from January 2012. METHODS: Under five children were enrolled through active surveillance at University Teaching Hospital using a standardized WHO case investigation form. Stool samples were collected from children who presented with ≥3 loose stool in 24 h and were admitted to the hospital for acute gastroenteritis as a primary illness. Samples were tested for group A rotavirus antigen enzyme-linked immunosorbent assay. Randomly selected rotavirus positive samples were analysed by reverse transcription polymerase chain reaction for G and P genotyping and and Nucleotide sequencing was used to confirm some mixed infections. RESULTS: A total of 4150 cases were enrolled and stool samples were collected from 4066 (98%) children between 2008 and 2011, before the vaccine was introduced. Rotavirus antigen was detected in 1561/4066 (38%). After vaccine introduction (2012 to 2015), 3168 cases were enrolled, 3092 (98%) samples were collected, and 977/3092 (32%) were positive for rotavirus. The most common G and P genotype combinations before vaccine introduction were G1P[8] (49%) in 2008; G12P[6] (24%) and G9P[8] (22%) in 2009; mixed rotavirus infections (32%) and G9P[8] (20%) in 2010, and G1P[6] (46%), G9P[6] (16%) and mixed infections (20%) in 2011. The predominant strains after vaccine introduction were G1P[8] (25%), G2P[4] (28%) and G2P[6] (23%) in 2012; G2P[4] (36%) and G2P[6] (44%) in 2013; G1P[8] (43%), G2P[4] (9%), and G2P[6] (24%) in 2014, while G2P[4] (54%) and G2P[6] (20%) continued to circulate in 2015. CONCLUSION: These continual changes in the predominant strains suggest natural secular variation in circulating rotavirus strains post-vaccine introduction. These findings highlight the need for ongoing surveillance to continue monitoring how vaccine use affects strain evolution over a longer period of time and assess any normal seasonal fluctuations of the rotavirus strains.
引用
- Simwaka JC, Mpabalwani EM, Seheri M, et al. Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015. Vaccine. 2018. PMID: 29907481. doi:10.1016/j.vaccine.2018.03.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。